Disparate chondrocyte metabolism in three-dimensional fibrin cultures derived from autogenous or commercially manufactured fibrinogen

American Journal of Veterinary Research

Volumn 59, Issue 4, 1998, Pages 514-520

  Fortier, Lisa A ^a   Brofman, Peter J ^a   Nixon, Alan J ^a   Mohammed, Hussni O ^a  

^a Department of Population Medicine and Diagnostic Sciences   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; FIBRIN; FIBRINOGEN; MESSENGER RNA; PROCOLLAGEN; PROTEOGLYCAN;

ANALYSIS OF VARIANCE; ANIMAL; ARTICLE; ARTICULAR CARTILAGE; BIOSYNTHESIS; CELL CULTURE; CELL DIVISION; CULTURE TECHNIQUE; CYTOLOGY; DRUG EFFECT; HORSE; ISOLATION AND PURIFICATION; METABOLISM; METHODOLOGY;

ANALYSIS OF VARIANCE; ANIMALS; CARTILAGE, ARTICULAR; CELL CULTURE TECHNIQUES; CELL DIVISION; CELLS, CULTURED; DNA; FIBRIN; FIBRINOGEN; HORSES; PROCOLLAGEN; PROTEOGLYCANS; RNA, MESSENGER;

EID: 0032040047     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (60)

1. Hendrickson DA, Nixon AJ, Grande DA, et al. Chondrocyte-fibrin matrix transplants for resurfacing extensive articular cartilage defects. J Orthop Res 1994;12:485-497.
2. Robinson D, Halperin N, Nevo Z. Long-term followup of the fate of xenogeneic transplants of chondrocytes implanted into joint surfaces. Transplantation 1991;52:380-383.
3. Vacanti CA, Langer R, Schloo B, et al. Synthetic polymers seeded with chondrocytes provide a template for new cartilage formation. Plast Reconstr Surg 1991;88:753-759.
4. Brittberg M, Lindahl A, Nilsson A, et al. Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation. N Engl J Med 1994;331:889-941.
5. Itay S, Abramovici A, Nevo Z. Use of cultured embryonal chick epiphyseal chondrocytes as grafts for defects in chick articular cartilage. Clin Orthop 1987;220:284-303.
6. Wakitani S, Goto T, Pineda SJ, et al. Mesenchymal cell-based repair of large, full-thickness defects of articular cartilage. J Bone Joint Surg Am 1994;76:579-592.
7. Sams AE, Nixon AJ. Chondrocyte-laden collagen scaffolds for resurfacing extensive articular cartilage defects. Osteoarthritis Cart 1995;3:47-59.
8. Grande DA, Singh IJ, Pugh J. Healing of experimentally produced lesions in articular cartilage following chondrocyte transplantation. Anat Rec 1987;218:142-148.
9. Caplan AI. Mesenchymal stem cells. J Orhop Res 1991;9: 641-650.
10. Vacanti CA, Kim W, Schloo B, et al. Joint resurfacing with cartilage grown in situ from cell-polymer structures. Am J Sports Med 1994;22:485-488.
11. Paige KT, Cima LG, Yaremchuk MJ, et al. De novo cartilage generation using calcium alginate-chondrocyte constructs. Plast Reconstr Surg 1996;97:168-178.
12. Pitman Ml, Menche D, Song E, et al. The use of adhesives in chondrocyte transplantation surgery: in vivo studies. Bull Hosp Joint Dis Orthop Inst 1989;49:213-220.
13. Sams AE, Minor RR, Wootton JAM, et al. Local and regional matrix responses to chondrocyte laden collagen scaffold implantation in extensive articular cartilage defects. Osteoarthritis Cart 1995;3:61-70.
14. Black J, Shadle CA, Parsons JR, et al. Articular cartilage preservation and storage II. Mechanical indentation testing of viable, stored articular cartilage. Arthritis Rheum 1979;22:1102-1108.
15. McIlwraith CW, Nixon AJ. Joint resurfacing: attempts at repairing articular cartilage defects. In: Mcllwraith CW, Trotter GT, eds. Joint disease in the horse. Philadelphia: WB Saunders Co, 1996; 317-344.
16. Cain JE, Dryer RF, Barton BR. Evaluation of dural closure techniques. Suture methods, fibrin adhesive sealant, and cyanoacrylate polymer. Spine 1988;13:720-725.
17. Weber SC, Chapman MW. Adhesives in orthopedic surgery. A review of the literature and in vitro bonding strengths of bone-bonding agents. Clin Orthop 1984;191:249-261.
18. Kram HB, Shoemaker WC, Hino ST, et al. Tracheal repair with fibrin glue. J Thorac Cardiovasc Surg 1985;90:771-775.
19. Matras H. Fibrin seal: the state of the art. J Oral Maxillofac Surg 1985;43:605-611.
20. Hauser CJ. Hemostasis of solid viscus trauma by intraparenchymal injection of fibrin glue. Arch Surg 1989;124:291-293.
21. Schlag G, Redl H. Fibrin sealant in orthopedic surgery. Clin Orthop 1988;227:269-285.
22. Kram HB, Del Junco T, Clark SR, et al. Techniques of splenic preservation using fibrin glue. J Trauma 1990;30:97-101.
23. Meyers MH, Herron M. A fibrin seal for the repair of osteochondral fracture fragments. Clin Orthop 1984;182:258-263.
24. Ochsner MG, Maniscalco-Theberge ME, Champion HR. Fibrin glue as a hemostatic agent in hepatic and splenic trauma. J Trauma 1990;30:884-887.
25. Redl H, Schlag G. Fibrin sealant and its modes of application. In: Schlag G, Redl H, eds. Fibrin sealant in operative medicine. 4th ed. Berlin: Springer-Verlag, 1986;13-26.
26. Ishimura M, Tamai S, Fujisawa Y. Arthroscopic meniscal repair with fibrin glue. Archroscopy 1991;7:177-181.
27. Kaplonyi G, Zimmerman I, Frenyo AD, et al. The use of fibrin adhesive in the repair of chondral and osteochondral injuries. Injury 1988;19:267-272.
28. Weidmann E, Hilfenhaus J. Fibrin glue safety: inactivation of potential viral contaminants by pasteurization of the human plasma components. Drug Res 1985;35:1617-1619.
29. Dresdale A, Rose EA, Jeevanandam V, et al. Preparation of fibrin glue from single-donor fresh-frozen plasma. Surgery 1985;97: 750-754.
30. Redl H, Schlag G. Principles of fibrin sealant and its mode of application. Facial Plast Surg 1985;2:315-321.
31. Siedentop KH, Harris DM, Sanchez B. Autologous fibrin tissue adhesive: factors influencing bonding power. Laryngoscope 1988;98:731-733.
32. Mosesson MW, Sherry S. The preparation and properties of human fibrinogen of relatively high solubility. Biochemistry 1966;5: 2829-2835.
33. Longas MO, Newman J, Johnson AJ. An improved method for the purification of human fibrinogen. Int J Biochem 1979;11:559-564.
34. Kazal LA, Amsel S, Miller OP, et al. The preparation and some properties of fibrinogen precipitated from human plasma by glycine. Proc Soc Exp Biol Med 1963;113:989-994.
35. Kjaergard HK, Weis-Fogh US, Sorensen H, et al. A simple method of preparation of autologous fibrin glue by means of ethanol. Surg Gynecol Obstet 1992;175:72-73.
36. Stechison MT. Rapid polymerizing fibrin glue from autologous or single donor blood: preparation and indications. J Neurosurg 1992;76:626-628.
37. Cohn EJ, Strong LE, Hughes WL, et al. Preparation and properties of serum and plasma proteins. IV. A system for the preparation into fractions of the protein and lipoprotein components of biological tissues and fluids. J Am Chem Soc 1946;68:459-475.
38. Nixon AJ, Lust G, Vernier-Singer M. Isolation, propagation, and cryopreservation of equine articular chondrocytes. Am J Vet Res 1992;53:2364-2370.
39. Sandell LJ. In situ expression of collagen and proteoglycan genes in notochord and during skeletal development and growth. Microsc Res Tech 1994;28:470-482.
40. Farndale RW, Buttle DJ, Barrett AJ. Improved quantitation and discrimination of sulphated glycosaminoglycans by use of dimethylmethylene blue. Biochem Biophys Acta 1986;883:173-177.
41. 35S-labeled proteoglycans complexed to alcian blue by rapid filtration in multiwell plates. Anal Biochem 1994;217:167-175.
42. Fortier LA, Nixon AJ, Mohammed HO, et al. Altered biological activity of equine chondrocytes cultured in a three-dimensional fibrin matrix and supplemented with transforming growth factor B1. Am J Vet Res 1997;58:66-70.
43. Kim Y, Sah RLY, Doong JH, et al. Fluorometric assay of DNA in cartilage explants using Hoechst 33258. Anal Biochem 1988; 174:168-176.
44. Trippel SB, Corvol MT, Dumontier MF, et al. Effect of somatomedin-C/insulin-like growth factor I and growth hormone on cultured growth plate and articular chondrocytes. Pediatr Res 1989; 25:76-82.
45. Denko CW, Boja B, Moskowitz RW. Growth promoting peptides in osteoarthritis: insulin, insulin-like growth factor-1, growth hormone. J Rheumatol 1990;17:1217-1221.
46. Makower A, Wroblewski J, Pawlowski A. Effects of IGF-1, rGH, FGF, EGF, and NCS on DNA synthesis, cell proliferation and morphology of chondrocytes isolated from rat rib growth cartilage. Cell Biol Int Rep 1989;13:259-270.
47. Hunziker EB, Wagner J, Zapf J. Differential effects of insulin-like growth factor 1 and growth hormone on developmental stages of rat growth plate chondrocytes in vivo. J Clin Invest 1994; 93:1078-1086.
48. Vetter U, Zapf J, Heit W, et al. Human fetal and adult chondrocytes: effect of insulin-like growth factors I and II, insulin, and growth hormone on clonal growth. J Clin Invest 1986;77:1903-1908.
49. Ohlsson C, Nilsson A, Isaksson OGP, et al. Effect of growth hormone and insulin-like growth factor-I on DNA synthesis and matrix production in rat epiphyseal chondrocytes in monolayer culture. J Endocrinol 1992;133:291-300.
50. McQuillan DJ, Handley CJ, Campbell MA, et al. Stimulation of proteoglycan biosynthesis by serum and insulin-like growth factor-1 in cultured bovine articular cartilage. Biochem J 1986;240:423-430.
51. Lindahl A, Nilsson A, Isaksson OGP. Effects of growth hormone and insulin-like growth factor-I on colony formation of rabbit epiphyseal chondrocytes at different stages of maturation. J Endocrinol 1987;115:263-271.
52. Baxter RC, Martin JL. Binding proteins for the insulin-like growth factors: structure, regulation and function. Prog Growth Fact Res 1989;1:49-68.
53. Skantze K, Brinckerhoff C, Collier J. Use of agarose culture to measure the effect of transforming growth factor B and epidermal growth factor on rabbit articular chondrocytes. Cancer Res 1985;45: 4416-4421.
54. Massague J. The transforming growth factor-B family. Annu Rev Cell Biol 1990;6:597-641.
55. Vivien D, Galera P, Loyau G, et al. Differential response of cultured rabbit articular chondrocytes (RAC) to transforming growth factor B (TGF-B) - evidence for a role of serum factors. Eur J Cell Biol 1991;54:217-223.
56. van der Kraan PM, Vitters EL, van den Berg WB. Inhibition of proteoglycan synthesis by transforming growth factor B in anatomically intact articular cartilage of murine patellae. Ann Rheum Dis 1992;51:643-647.
57. Denko CW, Boja B, Moskowitz RW. Growth factors, insulin-like growth factor-1 and growth hormone, in synovial fluid and serum of patients with rheumatic disorders. Osteoarthritis Cart 1996; 4:245-249.
58. Daughaday WH, Rotwein P. Insulin-like growth factor I and II. Peptide, messenger ribonucleic acid and gene structures, serum, and tissue concentrations. Endocr Rev 1989;10:68-91.
59. Hochberg MC, Lethbridge-Cejku M, Scott WW, et al. Serum levels of insulin-like growth factor 1 in subjects with osteoarthritis of the knee. Arthritis Rheum 1994;37:1177-1180.
60. Schneiderman R, Rosenberg N, Hiss J, et al. Concentration and size distribution of insulin-like growth factor-1 in human normal and osteoarthritic synovial fluid and cartilage. Arch Biochem Biophys 1995;324:173-188.